Oncology Life Sciences Industry Report - Oncology Developments in the oncology space in 2024 brought hope to both industry and patients.
Oncology Sponsored Patient Centricity to Integration: Enhancing Cancer Outcomes We are living in an era of unprecedented advances in cancer treatments with transformative therapies being regularly approved.
White Papers Sponsored How pharma can help the post-COVID recovery of European canc... The new Cancer Care in Europe: Recovering from COVID-19 Disruption white paper assesses the disruption to patient care and the changes physicians i
Oncology Sponsored Preparing for the next decade of innovation in immuno-oncolo... Immuno-oncology has seen some striking clinical advances in the 10 years since the approval of the first therapeutic cancer vaccine, but it’s a field that doesn’t stand still.
Debates & Insight Sponsored From promise to practice: immuno-oncology in action – the ne... Immuno-oncology therapies that harness the body's own defences to fight off tumours are widely acknowledged as the new frontier in cancer treatment.
News Bayer trial combines two top drugs for kidney disease Data from the CONFIDENCE trial shows the value of combining Bayer's Kerendia with an SGLT2 inhibitor to treat chronic kidney disease in diabetics.
